We will create a diverse, equitable and inclusive environment that treats all associates with dignity and respect.
At Novartis, we’re striving to build an inclusive and equitable workplace that empowers all of our associates to achieve their full potential. That’s why we’ve publicly committed to achieving gender balance in management by 2023 and ensuring pay equity and transparency for all of our associates globally.
Pay equity and transparency
Pay equity is a fundamental principle of our employment policies and is reflected in our commitment to treating all employees fairly and respectfully, as outlined in our Code of Ethics. Our commitment to pay equity and transparency led us to join the Equal Pay International Coalition (EPIC) in 2018. Learn more about our commitments.
We have established a multi-year program to implement global principles and processes to ensure pay equity and transparency across all our countries of operation by 2023. Our key actions include: use of objective internal and external benchmarking data to remove possible bias, removal of the use of historical salary data, annual pay equity analysis and adjustments, where appropriate, and transparent communication of individual pay position compared to internal and/or external benchmark data.
Gender balance in management
An overall gender pay gap is often caused by unequal representation of one gender in traditionally higher paid skill sectors and/or senior leadership levels. By focusing on achieving gender balance in management by 2023, we aim to positively influence the overall gender pay gap.
We know we have more work to do but we are making progress. Women currently make up 50% of our overall workforce, with 45% women in management and 25% women on our Board of Directors.
Globally, Novartis currently has a negative median pay gap of -3.1% and a global mean pay gap of 3.6%.
Additional steps we are taking toward gender balance include the use of balanced slates and interview panels in our recruitment practices and gender-neutral parental leave, as well as significantly expanding our flexible working opportunities through Choice with Responsibility.
We have established a Novartis gender strategy with tools to help leadership teams across the organization track their gender representation in both external applicants and current management population to help us work toward our aspiration for gender balance.
We have 20 LGBTI Employee Resource Groups in 14 countries. Our most recent global LGBTI Pride event saw more than 3,000 participants join from 67 countries across our organization.
We recognize that senior champions play a crucial role in setting an example for culture, behaviors and inclusion at Novartis. That is why we have established a senior leadership team who are active allies and advocate for LGBTI equality globally.
Mukul Mehta, Chief Financial Office Pharma
Tracy Furey, VP Global Head Communications and Advocacy
Ina Quinn, Global Head Manufacturing Functions
Jang-Ho Cha, TM Head, Neuroscience
Bruno Villetelle, Head of Data and Digital GDD
Inge Maes, Head People and Organization Sandoz
Rodrigo Reygadas, Head PLS/NGSC
Pierre Affaticati, Head of Medical Strategy AAA
Ben Kaye-Smith, VP Ethics, Risk and Compliance AveXis
Our culture is built on strong values and behaviors, underpinned by our Code of Ethics, that are designed to ensure our people feel safe, and are seen, heard and valued for who they are. We work to address all forms of discrimination or harassment, and provide our people with a safe and confidential process to report any misconduct.